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A B S T R A K  
 
Diabetes Mellitus adalah salah satu masalah kesehatan terbesar. HbA1c digunakan untuk 
mendiagnosis, memantau pengobatan dan penyesuaian pengobatan. Kromatografi Cair 
Kinerja Tinggi (HPLC) dan spektrometri massa semprotan elektron direkomendasikan 
untuk mengukur HbA1c. Namun kedua metode tersebut membutuhkan biaya yang mahal, 
fasilitas yang berpotensi menambah beban biaya kesehatan. Pengukuran HbA1c 
menggunakan Point of Care Testing (POCT) sedang dikembangkan di Indonesia. POCT lebih 
nyaman, biaya lebih terjangkau dan mudah dibawa ke pelayanan kesehatan primer. Tujuan: 
untuk menilai kemanjuran klinis POCT dibandingkan dengan pemeriksaan standar dengan 
HPLC. Metode: Merupakan penelitian potong lintang yang dilakukan di fasilitas kesehatan 
tingkat pertama (FKTP) di Malang. Populasi subjek adalah pasien rawat jalan di FKTP 
dengan kriteria inklusi berusia 20-75 tahun, merupakan peserta program penanganan 
penyakit kronis (PROLANIS), baik diabetes maupun non-diabetes. Hasil: Tiga ratus tiga 
puluh delapan subjek berpartisipasi dalam penelitian ini. Lima subjek dikecualikan karena 
adanya anemia. Kami menggunakan uji Wilcoxon untuk membandingkan kadar HbA1c 
antara dua metode dan uji korelasi Rank Spearman untuk menemukan korelasi antara dua 
metode. Hasil penelitian menunjukkan pengukuran kadar HbA1c dengan metode POCT 
memiliki akurasi yang baik (> 80%). Selain nilai diagnosis, peningkatan pemanfaatan POCT 
HbA1c mungkin juga disebabkan oleh portabilitas dan kenyamanan pasien. Kesimpulan: 
Adanya korelasi yang kuat (R = 0,016) antara POCT HbA1c dan pengukuran standar. POCT 
HbA1c juga menunjukkan akurasi yang baik pada semua kelompok HbA1c. 
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A B S T R A C T  
 
Diabetes Mellitus is one of the biggest health problems. HbA1c is used to diagnose, to 
monitor treatment and treatment adjustment. High Performance Liquid Chromatography 
(HPLC) and electron spray mass spectrometry are recommended to measure HbA1c. But 
both methods need expensive cost, facility, and potentially increase health cost burden. 
HbA1c measurement using Point of Care Testing (POCT) is developed in Indonesia. POCT is 
more comfortable, has lower cost and easily brought to primary health care. Aim: to assess 
the clinical efficacy of POCT compared with a standard examination by HPLC. Methods: It is 
a cross-sectional observational study conducted at a first-level health facility (FKTP) in 
Malang. The subject population was patients who went to an outpatient unit in FKTP with 
inclusion criteria aged 20-75 years, were participants in the chronic disease management 
program (PROLANIS), both diabetes and non-diabetes. Results: Three hundred and thirty-
eight subjects were participated in this study. Five subjects were excluded because the 
presence of anemia. We used Wilcoxon test to compare HbA1c level between two methods 
and Rank Spearman correlation test to find correlation between two methods. This study 
showed measurement HbA1c level using POCT method had good accuracy (>80%). Other 
than diagnosis value, increased utilization of POCT HbA1c might also be caused by its 
portability and patient’s comfort. Conclusions: This study showed a strong correlation 
(R=0.016) between POCT HbA1c and standardized measurement. POCT HbA1c also showed 
good accuracy in all HbA1c groups. 
 
Keywords: diabetes mellitus, HbA1c, High Performance Liquid Chromatography (HPLC), 
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I N T R O D U C T I O N
Diabetes Mellitus (DM) is one of the 
biggest health problems in the twenty-first 
century. At present, there are an estimated 
415 million people with diabetes worldwide 
and 318 million people with impaired glucose 
tolerance that have the potential to become 
diabetes.[1] Data released from the results of 
basic health research (RISKESDAS) show that 
the prevalence of diabetes in Indonesia is 5.7% 
while the prevalence of people with impaired 
glucose tolerance or who are often grouped 
into prediabetes is 10.2%.[2]  
The diagnosis of DM can be made by 
using fasting blood glucose (GDP) or blood 
glucose testing 2 hours after 75 grams of 
glucose (OGTT) or by HbA1c. These three 
examinations have the same place in 
establishing the diagnosis of DM. [3,4] In 
addition to establish the diagnosis, blood 
glucose, and HbA1c checks are also important 
to carry out monitoring that could be used as a 
guide to improve management such as 
changes in diet / physical activity or adjusting 
the dose of drugs/insulin. [5,6]  
Two large-scale studies, Diabetes 
Control and Complications Trial (DCCT) and 
the United Kingdom Prospective Diabetes 
Study (UKPDS) showed that intensive therapy 
using HbA1C as a target can reduce the risk of 
developing microvascular complications. The 
decrease in HbA1C is identical to the reduced 
risk of diabetes-related complications. Data 
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from UKPDS shows that each 1% decrease 
in HbA1c, it will decreases the relative risk of 
myocardial infarction by 14% and the risk 
of microvascular complications by 37%.[7] 
Besides, HbA1c examination is an indirect test 
to measure the average blood glucose. Several 
other factors can affect HbA1c such as age, 
race/ethnicity, the presence of anemia 
/hemoglobinopathy, history of blood 
transfusion in the last 2-3 
months and disorders of kidney function. [8,9] 
Guidelines issued by the American 
Diabetes Association (ADA) as well as from the 
Indonesian Endocrinologist (PERKENI) states 
examination of HbA1c for diagnosis must use 
methods that certified by the National 
Glycohemoglobin Standardization Program 
(NGSP) and standardized by studies from 
Diabetes Control and Complications Trial 
(DCCT).[3,4] In Indonesia, not all laboratories 
use NGSP standards, accuracy and caution are 
needed in interpreting 
the HbA1C examination. 
High-Performance Liquid Chromato-
graphy (HPLC) and electron spray mass 
spectrometry are some of the methodologies 
that used as a reference for measuring HbA1c, 
still both of these checks require substantial 
costs, facilities and infrastructure.[10] This 
indeed becomes a problem related to financing 
that must be issued by the country if this 
examination is a routine examination for 
diabetic patients in Indonesia. 
In recent months, the HbA1c 
examination with Point of Care Testing 
(POCT) is developed in Indonesia. POCT is a 
method of the investigation carried out 
outside a central laboratory that uses tools. 
Some of the advantages of this POCT 
examination include: providing real-time 
results so that doctors can immediately 
provide motivation and management plans 
based on the results obtained; using capillaries 
so that the patient is more comfortable; and is 
cheaper and easier to carry to primary health 
facilities. [5, 11-14] 
This POCT examination has not 
recommended for the diagnosis of T2DM. This 
examination has several shortcomings, such as 
the absence of evidence that states that this 
examination will provide better outcomes for 
patients, better optimize diabetes services, 
and improve HbA1C. Besides, standardization 
of the use of HbA1C is also still not available 
properly. [15-19] For this reason, a study aimed 
at assessing the clinical effectiveness of POCT, 
which includes its accuracy is compare with a 
standard examination by the HPLC method. 
M E T H O D S 
Study Design 
This study is a cross-sectional 
observational study conducted at a first-level 
health facility (FKTP) in Malang. The subject 
population was patients who went to an 
outpatient unit in FKTP with inclusion criteria 
aged 20-75 years, were participants in the 
chronic disease management program 
(PROLANIS), both diabetes and non-diabetes. 
While the exclusion criteria are hemoglobin 
levels <10 gr/dl or hemoglobinopathy. This 
study was approved by Ethics commitee of 
General Hospital dr. Saiful Anwar Malang. 
Sample size  
The prevalence of type 2 diabetes and 
glucose intolerance in Indonesia is currently 
5.7% and 10.2%. An expected sensitivity level 
of 80% and an error rate of 5%, as many as 307 
subjects need in this study. 
Study procedures  
The study carried out after the patient 
signed the consent form following this study. 
The patient was anamnesis and 
anthropometric, physical examination 
including blood pressure, body mass index. 
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Then the HBA1C POCT examination was 
carried out in the form of capillary blood 
followed by venous blood sampling to examine 
the Hba1C by the HPLC method. POCT 
examination uses Borronate affinity Tri-statTM 
technology. The analysis of the HPLC method 
uses Premier Hb9210TM. The HbA1c results 
grouped into three groups, namely groups 
with HbA1c <5.7%, groups with HbA1c ≥ 
6.5%, and groups with HbA1c ≤ 7%. Complete 
blood tests are also perform to rule out anemia 
(Hb <10g / dl) and hemoglobinopathy. 
Statistical Analysis 
We used paired t-tests to compare 
HbA1c levels from the two methods or 
alternative statistical analysis which 
appropriate with types of the data. Analysis of 
sensitivity, specificity, positive predictive 
value, and accuracy. All data were analysed by 
computerization using Statistical Product and   
Service Solution software, IBM SPSS Statistics 
20, with a significance level of 0.05 (α=0.05). 
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R E S U L T S 
There were 338 subjects who participated in this study. Five subjects were excluded due to 
anemia, resulting in a total of 333 subjects. Based on Figure 1, it can be seen Correlation test results 
showed a significant correlation between POCT HbA1c levels with standard HbA1c levels. The 
correlation value is 91.6% and it has positive correlation. It means that the higher the POCT HbA1c 
levels, the higher HbA1c levels obtained by the standard HPLC method. 
 
Figure 1. Correlation of POCT HbA1c levels with standard HbA1c 
 
3.1 Group of Diabetic Patient with HbA1c           < 
5.7 % 
The results of cross-tabulation, POCT 
HbA1c with standard HbA1c for groups with 
HbA1c levels <5.7% can be seen in Table 1. 
Table 1.  POCT HbA1c levels compared to standard 




< 5.7 ≥ 5.7 
< 5.7 18 52 70 
≥ 5.7 6 257 172 
Total 24 309 333 
*POCT, Point of Care Testing; HbA1c, Haemoglobin A1c 
In this group, POCT sensitivity was 
0.79, specificity was 0.99, positive predictive 
value was 0.98, and the negative predictive 
value was 0.82. The method accuracy is 
outstanding (0.89 / 88.89%) 
 
3.2 Group of Diabetic patient with HbA1c ≥ 6.5 
% 
The results of cross-tabulation (table 
2x2) POCT HbA1c with standard HbA1c for 
groups with HbA1c levels ≥ 6.5% can be seen 
in Table 2. 
Table 2.  POCT HbA1c levels compared to standard 
HbA1C levels for HbA1c ≥ 6.5 %. 









Table 3.  POCT HbA1c levels compared to standard 
HbA1C levels for HbA1c ≤ 7 %. 

























≤ 6.5 >6.5 
≤ 6.5 123 38 161 
> 6.5 5 167 172 
Total 128 205 333 
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≤ 7 > 7 
≤ 7 163 35 198 
>7 2 133 135 
Total 168 165 333 
*POCT, Point of Care Testing; HbA1c, Haemoglobin A1c  
In this group, POCT sensitivity was 
0.79, specificity was 0.99, positive predictive 
value was 0.98, and the negative predictive 
value was 0.82. The method accuracy is 
excellent (0.89/ 88.89%) 
D I S C U S S I O N 
Overall, the results of this study 
indicate that the use of the POCT HbA1c 
examination has reasonably good accuracy (> 
80%) compared to the standard examination 
for HbA1c. These results are the same as the 
study conducted by Wiwanitkit, et al. from 
Thailand who saw a correlation between the 
POCT HbA1c examination and with the 
standard HbA1c examination tool with a 
correlation coefficient (R) 0.99.[19] It is not too 
different from our study where we obtained a 
correlation coefficient (R) between the two 
examinations amounting to 0.92. Likewise, a 
comparative study conducted by Sicard, et al. 
in 23 patients found a reasonably good 
correlation (r = 0.76) between the two 
methods used for this HbA1c examination.[20] 
The same results in terms of accuracy also 
reported by Knaebell, et al. testing 3 POCT 
HbA1c devices at the same time compared to 
the standard where the correlation coefficient 
is 0.98, 0.99 and 0.99.[12] In addition to 
diagnostic values, POCT HbA1c is increasingly 
used because it is more economical than 
standard inspection, is portable, so it is easy to 
be moved and used, and greater satisfaction 
from the patient's side.[21,22] 
C O N C L U S I O N 
The results of this study show a strong 
correlation (r = 0.916) between POCT HbA1c 
and standard inspection. They also obtained 
useful accuracy data from the use of POCT 
HbA1c in all groups. 
This study can be a basis for 
consideration of the use of POCT HbA1c in 
FKTP as part of the management of Diabetes 
Mellitus Type-2. However, it is always 
necessary to understand the limitations of 
using all diagnostic tools to avoid the results 
misinterpretation. 
R E F E R E N C E S 
1. Cho NH, Whiting D, Forouhi N, Guariguata L, 
Hambleton I, Li R, et al. IDF Diabetes Atlas In: 
Federation ID, editor. 2015. 
2. Soendoro T. Riset kesehatan dasar (RISKESDAS) 
2007. In: Health Mo, editor. Jakarta: Badan 
Penelitian dan Pengembangan Kesehatan 
Departemen Kesehatan Republik Indonesia. 2008. 
3. Cefalu WT. American diabetes association 
standards of medical care in diabetes 2017. 
Diabetes Care. 2017;40(Supplement 1). 
4. Soelistijo SA. Konsensus pengelolaan dan 
pencegahan diabetes melitus di Indonesia 2015. 
2015. 
5. Al-Ansary L, Farmer A, Hirst J, Roberts N, Glasziou 
P, Perera R, et al. Point-of-care testing for Hb A1c in 
the management of diabetes: a systematic review 
and metaanalysis. Clinical chemistry. 
2011;57(4):568-76.  
[doi: 10.1373/clinchem.2010.157586] 
6. Bubner TK, Laurence CO, Gialamas A, Yelland LN, 
Ryan P, Willson KJ, et al. Effectiveness of point-of-
care testing for therapeutic control of chronic 
conditions: results from the PoCT in General 
Practice Trial. The Medical journal of Australia. 
2009;190(11):624-6. [PMID: 19485840] 
7. Kahn CR, Weir GC, King GL, Smith RJ. Joslin's 
Diabetes Mellitus. 2000. 
8. Camargo JL, Gross JL. [Glycohemoglobin (GHb): 
clinical and analytical aspects]. Arq Bras 
Endocrinol Metabol. 2004;48(4):451-63. [doi: 
10.1590/s0004-27302004000400005] 
9. Lenters-Westra E, Schindhelm RK, Bilo HJ, 
Slingerland RJ. Haemoglobin A1c: historical 
overview and current concepts. Diabetes research 
and clinical practice. 2013;99(2):75-84. [doi: 
10.1016/j.diabres.2012.10.007 ] 
10. Penttila I, Penttila K, Holm P, Laitinen H, Ranta P, 
Torronen J, et al. Methods, units and quality 
requirements for the analysis of haemoglobin A1c 
in diabetes mellitus. World journal of methodology. 
2016;6(2):133-42. [doi: 10.5662/wjm.v6.i2.133] 
11. Ejilemele A, Unabia J, Ju H, Petersen JR. A1c Gear: 
laboratory quality HbA1c measurement at the 
point of care. Clinica chimica acta; international 
journal of clinical chemistry. 2015; 445:139-42. 
Rosandi R, et al.  CRJIM  1 (2): November 2020 
 
| 69  
 
12. Knaebel J, Irvin BR, Xie CZ. Accuracy and clinical 
utility of a point-of-care HbA1c testing device. 
Postgraduate medicine. 2013;125(3):91-8. 
13. Leal S, Soto-Rowen M. Usefulness of point-of-care 
testing in the treatment of diabetes in an 
underserved population. Journal of diabetesscience 
and technology. 2009;3(4):672-6. [doi: 
10.1177/193229680900300409] 
14. Spaeth BA, Shephard MD, Schatz S. Point-of-care 
testing for haemoglobin A1c in remote Australian 
Indigenous communities improves timeliness of 
diabetes care. Rural and remote health. 
2014;14(4):2849. [PMID: 25359698] 
15. Manley SE, Hikin LJ, Round RA, Manning PW, Luzio 
SD, Dunseath GJ, et al. Comparison of IFCC-
calibrated HbA(1c) from laboratory and point-of-
care testing systems. Diabetes research and clinical 
practice. 2014;105(3):364-72. [PMID: 24985893] 
16. The use of POCT HbA1c devices in the NHS Diabetes 
Prevention Programme: Recommendations from 
an expert working group commissioned by NHS 
England. 2014. [Corpus ID: 56966705] 
17. Sanchez-Mora C, M SR-O, Fernandez-Riejos P, 
Mateo J, Polo-Padillo J, Goberna R, et al. Evaluation 
of two HbA1c point-of-care analyzers. Clinical 
chemistry and laboratory medicine. 
2011;49(4):653-7. [PMID: 21323623] 
18. Shephard MD, Mazzachi BC, Shephard AK, 
McLaughlin KJ, Denner B, Barnes G. The impact of 
point-of-care testing on diabetes services along 
Victoria's Mallee Track: results of a community-
based diabetes risk assessment and management 
program. Rural and remote health. 2005;5(3):371. 
[PMID: 16026194] 
19. Wiwanitkit V. Hemoglobin A1C determination by 
point-of-care testing: its correlation to standard 
method. Diabetes & metabolic syndrome. 
2012;6(2):110-1. [ doi:10.1016/j.dsx.2012.08.014] 
20. Sicard DA, Taylor JR. Comparison of point-of-care 
HbA1c test versus standardized laboratory testing. 
The Annals of pharmacotherapy. 
2005;39(6):1024-8. 
21. [doi: 10.1345/aph.1E504] 
22. El-Osta A, Woringer M, Pizzo E, Verhoef T, Dickie C, 
Ni MZ, et al. Does use of point-of-care testing 
improve cost-effectiveness of the NHS Health Check 
programme in the primary care setting? A cost-
minimisation analysis. BMJ open. 2017;7(8): 
e015494. [doi: 10.1136/bmjopen-2016-015494 ] 
23. Crocker B, Lewandrowski EL, Lewandrowski N, 
Gregory K, Lewandrowski K. Patient satisfaction 
with point-of-care laboratory testing: report of a 
quality improvement program in an ambulatory 
practice of an academic medical center. Clinica 
chimica acta; international journal of clinical 
chemistry. 2013; 424:8-11. 
[doi: 10.1016/j.cca.2013.04.025 ] 
 
 
Cite this as:  
Rosandi R, Sasiarini L, Rudijanto A.  Comparison of 
Diagnostic Value between Point of Care Testing 
(POCT) and Standardize HbA1c Testing in Primary 
Health Care. Clinical and Research Journal in Internal 
Medicine. 1.2 (2020): (63-69) 
